After a prolonged period of decline, cervical cancer rates in Canada have stabilized, as reported by the Canadian Cancer Society. This concerning development contrasts with the previous declining trend observed between 1984 and 2005. A recent report by the Canadian Cancer Statistics Advisory Committee indicates that there has been a plateau in the annual percentage change of cervical cancer rates, hovering just below zero from 2005 to 2021.
While cervical cancer is not a leading cause of cancer-related deaths among females in Canada, the report emphasizes that each of the anticipated 430 deaths in 2025 due to this cancer could have been prevented. The disease is largely preventable through the administration of vaccines against and screening for human papillomavirus (HPV), a sexually transmitted infection responsible for cervical cancer and certain head and neck cancers.
Despite global efforts to eradicate cervical cancer, with the World Health Organization aiming to reduce incidence to less than four cases per 100,000 females worldwide, Canada has set a target to eliminate the disease domestically by 2040. However, Brandon Purcell, an advocacy manager at the Canadian Cancer Society, expresses concern that current trends may hinder achieving this goal.
The data highlights a troubling plateau in cervical cancer rates attributed to lower HPV vaccination rates, reduced screening practices, and deficiencies in follow-up care. This news is disheartening to individuals like Shannon Pethick, who underwent extensive radiation and chemotherapy treatments following a cervical cancer diagnosis at the age of 32. Pethick emphasizes the importance of regular screenings and prevention methods, underscoring the minimal inconvenience of such procedures compared to the potential consequences of neglecting them.
Experts suggest that enhancing vaccination programs, expanding screening accessibility, and transitioning to HPV testing for cervical cancer diagnosis could help Canada regain momentum towards meeting its 2040 elimination target. Dr. Amanda Selk, an obstetrician gynecologist, advocates for innovative screening approaches, such as at-home testing, to reach individuals who face barriers to traditional healthcare access.
Implementing at-home testing nationwide and replacing traditional pap smears with HPV tests are recommended strategies to improve early detection of cervical cancer. The effectiveness of the HPV vaccine in preventing cervical cancer is underscored by research findings, with Scotland reporting zero cases among fully vaccinated young women. Encouraging vaccination among school-aged children and ensuring universal access to the HPV vaccine are critical steps to boost protection against HPV-related cancers.
Countries like Sweden have successfully employed unconventional vaccination campaigns, such as partnering with movie theatres to offer incentives like movie tickets alongside HPV shots, to increase vaccination rates. These initiatives, along with comprehensive screening and vaccination strategies, are crucial in the fight against cervical cancer. Beyond cervical cancer, the overall cancer survival rate in Canada has shown improvement, with advancements in treatment and decreasing mortality rates for lung and colorectal cancers in recent years.